On Demand Webinar

IEC 60601-1 Testing: How the Process Works and What to Expect

Most IEC 60601-1 testing failures are not caused by bad engineering. They are caused by decisions made too early, too late, or in isolation. In this on-demand webinar, Element product safety expert Bob Burek walks through the IEC 60601-1 testing process from construction review to formal compliance testing, explaining what test laboratories actually look for, where programs go wrong, and what the teams that get it right do differently. 

Bob draws on his experience across hundreds of medical device evaluations to cover the practical decisions that determine whether formal testing produces a clean result or triggers redesign. That includes construction review criteria, component pre-selection, power supply compliance, how to sequence EMC and safety testing, what test plans must contain, and the documentation regulators will review closely. 

If you are preparing for IEC 60601-1 testing for the first time, or if a previous program ran over time or budget, this webinar covers the decisions that make the difference. Read it alongside our IEC 60601 medical device compliance whitepaper, which covers the standard structure and global regulatory pathways in depth. 

Why Watch This IEC 60601-1 Testing Webinar? 

This webinar is not an introduction to the IEC 60601 standard. It is a process guide for engineers and compliance managers who are actively working on a compliance program and want to understand what actually happens during formal testing, what can go wrong, and how to avoid it.  

After watching this webinar you will be able to: 

  • Sequence EMC pre-scans, design reviews, and formal safety testing to reduce the risk of late-stage failures 
  • Identify the construction review criteria that stop programs before testing begins 
  • Build a test plan that satisfies the FDA and holds up under regulatory scrutiny 
  • Pre-select power supplies and components against the right certification levels and conditions of acceptability 
  • Define essential performance early enough to shape your test scope and pass-fail criteria 
  • Assess the retesting implications of hardware changes to already-approved devices 

Key Topics Covered in This IEC 60601-1 Testing Webinar 

The webinar covers the IEC 60601-1 construction review process and why it happens before formal testing. It explains how to sequence EMC pre-scans, design reviews, and formal safety testing to reduce the risk of late-stage failures. It covers what a strong test plan must contain and why the FDA and other regulators review test plans closely. Bob also works through power supply and component pre-selection in detail, explaining what conditions of acceptability mean in practice and where off-the-shelf choices commonly fall short. 

The webinar addresses essential performance definition, including how it shapes your test scope and what happens when it is left too vague. It covers risk management under ISO 14971 and what reviewers expect to see in a risk file. It also covers how to handle design changes to already-approved devices. For teams working on connected or wireless medical devices, the regulatory approval section covers the parallel requirements across FDA, NRTL, FCC, EU MDR, and the CB Scheme. For a deeper look at wireless compliance specifically, see our wireless medical device compliance whitepaper. 

What Is the IEC 60601-1 Construction Review and Why Does It Come First? 

Before formal testing begins, a test laboratory conducts a construction review: a physical inspection of the device against the construction requirements of IEC 60601-1. This covers enclosure design, board-level spacings, ventilation, markings, wiring, and the compliance status of safety-critical components. 

The reason construction review precedes testing is direct. If the construction is sound, the testing should go well. Testing essentially proves the construction is adequate. But passing tests does not mean you will meet the construction requirements, because many construction requirements do not have associated tests. They are dimensional or qualitative criteria. The only way to confirm them is by inspection. 

When Element's construction review identifies serious issues, such as enclosure problems or inadequate board-level spacings, we flag them before testing begins. That gives the manufacturer time to consider a redesign without spending budget on formal testing that would not produce a usable result. It is worth noting that incorrect markings, missing risk management files, and inadequate component approvals are among the most common reasons medical devices fail safety testing. Most are detectable during construction review. 

What the Construction Review Examines 

A typical IEC 60601-1 construction review covers electrical insulation and creepage and clearance distances, fire enclosure requirements, flammability ratings of materials, mechanical stress resistance and impact testing criteria, wire gauges and routing, ventilation design, device markings, and the accompanying documentation, including instructions for use. 

Component certifications require particular scrutiny. A CE marking on a component is a manufacturer's self-declaration. It is not the same as a third-party certification from an accredited test laboratory. For safety-critical components, what the marking covers, which countries it applies to, and which version of the relevant standard was used all matter. A component with a CE marking but without independent certification backing is not the same as a component with a UL, TUV, or equivalent mark for the target market. 

How to Sequence IEC 60601-1 Testing for Best Results 

The order in which testing happens is one of the most practical decisions in an IEC 60601-1 program. The clear recommendation, based on experience across hundreds of programs, is to start with EMC testing before formal electrical product safety testing. 

The reasoning is straightforward. EMC modifications are more likely to affect product safety than the reverse. If safety testing comes first and an EMC problem then requires a hardware change, you may need to retest safety. Starting with an EMC pre-scan on an early prototype, before the design is locked, catches grounding, shielding, and layout issues at the point when they are cheapest to fix. 

The Recommended Testing Sequence 

  • Run an EMC pre-scan on an early prototype to identify grounding, shielding, or layout issues before the design is finalised 
  • Conduct a design review for electrical product safety, covering construction requirements, component pre-selection, and essential performance definition 
  • Develop a test plan and have it reviewed by the test laboratory before formal testing begins 
  • Conduct formal IEC 60601-1-2 EMC testing as the first step of the final compliance program 
  • Conduct formal electrical product safety testing including construction review, leakage current, insulation, temperature, and mechanical tests 

This sequence reduces the likelihood that changes driven by EMC results require safety retesting, and it ensures the sample submitted for formal safety testing reflects the final manufactured configuration. 

What IEC 60601-1 Test Plans Must Include 

Test plans are mandatory for IEC 60601-1 compliance, particularly for EMC. The FDA reviews test plans as part of its submission review and expects to see that the test laboratory followed them. A test plan that is incomplete or inconsistent with the final test report creates problems for the regulatory submission. 

A strong test plan defines the device configuration and operating modes to be tested, the acceptance criteria for each test, including essential performance thresholds, the environments of intended use, and any deviations from standard test conditions. For EMC, Annex G of IEC 60601-1-2 and its companion document IEC 60601-4-2 are the right starting points for structure and content. 

The acceptance criteria question catches many teams out. Some tests have a clear pass or fail threshold defined in the standard. Others, particularly those involving essential performance under EMC immunity conditions, require the manufacturer to define what level of degradation is acceptable. That definition has to exist before testing begins. If it does not, the test laboratory cannot make a defensible pass or fail decision, and the results may be challenged during regulatory review.

IEC 60601-1 Power Supply Compliance: What to Check Before You Integrate 

Power supply selection is one of the most consequential compliance decisions in a medical device program. Off-the-shelf power supplies and battery packs are often assumed to be compliant by default. The assumption is wrong. Integration choices introduce risks that the component certification alone does not cover, and fusing and isolation issues discovered during construction review are among the most common causes of program delays. 

Key Compliance Checks for Off-the-Shelf Power Supplies 

The power supply should be certified to IEC 60601-1, not a different standard such as IEC 62368 for information technology equipment. Where the device only requires operator protection rather than patient isolation, a 62368-certified supply may be acceptable in limited cases, but confirm this with the test laboratory before committing to the design. 

Revision level matters. A supply certified to an earlier amendment of IEC 60601-1 may create compliance problems if the end product is being tested to Edition 3.2. Amendment-level differences are often manageable, but differences across major editions are a serious concern that requires early discussion. 

The conditions of acceptability for the power supply must match or exceed those of the end product. This includes operating temperature range, altitude rating, shock and vibration capability, pollution degree, and input voltage range. A supply designed for clean indoor use at standard altitude will not meet the requirements of a device intended for air ambulance deployment. 

Fusing is a specific area where problems consistently arise. The fuse inside the power supply may not have adequate breaking capacity for the branch circuit the device connects to. Additional inline fusing before the power supply input may be required. This comes up regularly during construction reviews and is cheaper to address during design than after testing has begun. 

Essential Performance in IEC 60601-1 Testing: How It Shapes Your Test Scope 

IEC 60601-1 defines essential performance as the performance of a clinical function, other than basic safety, where loss or degradation beyond a defined limit would create unacceptable risk. The infusion pump is the example Bob returns to repeatedly: too much or too little medication delivered has severe patient consequences. That accuracy is essential performance, and its definition belongs in the device's design documentation from the earliest stage. 

The manufacturer is responsible for defining essential performance. Some particular standards in the IEC 60601-2-XX series list minimum essential performance requirements for specific device types, but those lists are not exhaustive and do not replace the manufacturer's own judgment about what applies to their device. Where there is no applicable particular standard, essential performance is defined entirely through risk assessment and knowledge of predicate devices. 

During testing, essential performance definitions directly shape the scope. EMC immunity tests, including radiated immunity, conducted immunity, and electrostatic discharge, are evaluated against essential performance criteria. If the definition is vague when testing begins, the test scope is difficult to justify and the results may be challenged. Define it during concept development, link it to the ISO 14971 risk management file, and document the rationale. That way, test decisions are traceable from the start. 

IEC 60601-1 Risk Management: What Test Laboratories Review Under ISO 14971 

Risk management under ISO 14971 is embedded throughout IEC 60601-1, not separate from it. During medical device safety testing, the test laboratory reviews the risk management file for completeness and alignment with the standard's requirements. 

A common failure in risk files is being too general. Writing "complies with IEC 60601-1" as the mitigation for an electrical insulation hazard is not sufficient. The standard contains numerous specific electrical insulation requirements. The risk analysis needs to show how each applicable requirement is addressed, not just assert that the device intends to comply. A risk file that is vague will not survive regulatory scrutiny. 

ISO 14971:2019 Annex C provides hazard identification guidance, but it is deliberately broad. IEC 60601-1 Annex A is a more useful supplementary resource because it contains the rationale behind specific requirements, which helps identify what the standard is trying to prevent and how your risk controls should respond. Using both together gives a more complete picture than relying on ISO 14971 alone. 

A well-built risk management file from the first generation of a product is also the most efficient starting point for a next-generation development. The hazard identification work, the risk control decisions, and the documented rationale do not expire. They provide the baseline from which changes can be assessed without starting from scratch. 

Making Changes to an Already-Approved IEC 60601-1 Device 

Component obsolescence, supply chain changes, and product improvements all lead to hardware modifications in approved devices. Not all changes trigger full retesting, but the scope depends on what changed and how it interacts with the existing compliance basis. 

A power supply change is one of the most consequential modifications a manufacturer can make. Swapping to a different supply, even one that appears equivalent, can simultaneously affect leakage current, isolation levels, EMC performance, and fusing. A construction review and targeted retesting are often required. The conditions of acceptability for the new supply need to be verified against those of the end product. 

Enclosure material changes can affect flammability compliance. If the original device relied on flame-retardant materials to exempt certain fault condition tests, replacing those materials with lower-rated alternatives removes that exemption. Additional testing may be required to demonstrate that the device is not a fire hazard without the flame-retardant protection. 

The consistent recommendation is to call the test laboratory before implementing any hardware change to an approved device. In many cases, the impact is minor, and the required retesting is limited. But finding out that a change has broader compliance implications after it has been implemented in production is significantly more expensive than a pre-change consultation.

IEC 60601-1 Testing and Regulatory Approval: What Passing Tests Do Not Guarantee 

Passing IEC 60601-1 tests is necessary but not sufficient to place a device on the market or deploy it in a healthcare facility. In the US, FDA submission, NRTL workplace safety certification, and, for wireless devices, FCC certification are three separate requirements governed by three separate authorities. A device with FDA clearance but no NRTL certification cannot legally be used in a US hospital or clinic. Many manufacturers learn this after FDA clearance is already in hand. 

In Canada, Health Canada submissions require compliance with the CAN/CSA version of IEC 60601-1, and ISED certification covers wireless transmitters. In Europe, the EU MDR 2017/745 requires technical file review and, for higher-risk devices, Notified Body assessment. The IECEE CB Scheme reduces duplicated testing by enabling mutual recognition of test reports across more than 50 member countries, making it one of the most efficient tools available for manufacturers targeting multiple markets. 

Planning for all of these pathways from the start of the compliance program, rather than addressing them after IEC 60601-1 testing is complete, compresses overall time to market. Element's medical device regulatory services team maps the full approval pathway for target markets before testing begins, identifying all parallel requirements and where they can share test data.

IEC 60601-1 Testing: The Decisions That Determine the Outcome 

IEC 60601-1 testing rarely fails because of the standard itself. It fails because power supplies were selected without verifying conditions of acceptability, essential performance was defined too late to shape the test scope, construction issues surfaced during the laboratory review that were never checked during design, or EMC modifications forced safety retesting. 

Getting IEC 60601-1 testing right depends on decisions made weeks or months before you walk through the laboratory door. Design reviews, test plan preparation, essential performance definition, and component pre-selection are where programs succeed or fail. By the time formal testing begins, the outcome is largely determined. 

If you want to go deeper on the IEC 60601 standard structure, collateral and particular requirements, and global regulatory pathways, download our IEC 60601 medical device compliance whitepaper. If you are ready to discuss your specific program, talk to one of our experts. 

Related Services

Medical Device EMC Testing

Medical Device EMC Testing

Element provides EMC testing and certification for Class I-III medical devices, helping manufacturers meet global regulatory standards and accelerate market entry with expert guidance and accredited laboratories.

IEC 60601 2018-02-02

IEC 60601 Medical Device Testing Services

Element provides testing and certification to IEC 60601 to assess the safety and essential performance of electrical medical devices.

Connected Technologies - Medical

Wireless Medical Device Testing Services

Accelerate your wireless medical device’s journey to market with Element's comprehensive testing solutions. From remote patient-monitoring systems to IoT-enabled devices – Learn More.

medical device regulatory services

Medical Device Regulatory Services

Element offers expert medical device regulatory consulting, guiding you through design, risk analysis, and FDA submissions for efficient product approval.

Speak to our team of experts

AMERICAS

Toll free from US lines

+1 888 786 7555

EUROPE

Contact our Central Team
UK

Freephone from UK

+44 808 234 1667

Germany

Freephone from Germany 

+49 800 000 5137

MIDDLE EAST

Toll free from UAE

+971 800 353 6368